Loading...
XTSXNXG
Market cap11mUSD
Oct 21, Last price  
0.40CAD
Name

NexgenRx Inc

Chart & Performance

D1W1MN
XTSX:NXG chart
P/E
—
P/S
2.03
EPS
—
Div Yield, %
3.21%
Shrs. gr., 5y
0.67%
Rev. gr., 5y
22.14%
Revenues
14m
+49.28%
3,377,7424,291,2164,503,1625,093,4127,191,8888,157,8839,318,6149,275,61313,846,329
Net income
-332k
L+1,908.90%
-135,573438,316-499,546-510,222-160,3501,660,7023,176,535-16,525-331,970
CFO
1m
-49.06%
-2,871,000-3,470,000-3,143,000-1,178,517-435,078-263,350-150,053455,651774,075-558,182-25,151366,104-206,909-3,587,987-1,201,964-721,4772,366,6912,507,3871,277,346
Earnings
May 15, 2025

Profile

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers prescription drug claims; dental claims; and claims for the extended health benefits, as well as a health care spending account that provides an amount of money to an individual to pay for health or dental benefits. The company also offers individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
URL
https://www.nexgenrx.com/
IPO date
Sep 14, 2006
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
13,846
49.28%
9,276
-0.46%
Cost of revenue
4,301
4,222
Unusual Expense (Income)
NOPBT
9,546
5,054
NOPBT Margin
68.94%
54.48%
Operating Taxes
27
116
Tax Rate
0.28%
2.29%
NOPAT
9,519
4,938
Net income
(332)
1,908.90%
(17)
-100.52%
Dividends
(902)
(665)
Dividend yield
Proceeds from repurchase of equity
62
BB yield
Debt
Debt current
59
31
Long-term debt
864
678
Deferred revenue
Other long-term liabilities
(102)
Net debt
(953)
(12,059)
Cash flow
Cash from operating activities
1,277
2,507
CAPEX
(77)
(374)
Cash from investing activities
(248)
(374)
Cash from financing activities
(919)
(819)
FCF
9,326
4,720
Balance
Cash
1,877
12,768
Long term investments
Excess cash
1,184
12,304
Stockholders' equity
3,332
20,757
Invested Capital
6,992
(5,456)
ROIC
1,239.28%
ROCE
116.74%
73.79%
EV
Common stock shares outstanding
70,531
70,336
Price
Market cap
EV
EBITDA
10,853
6,090
EV/EBITDA
Interest
38
113
Interest/NOPBT
0.40%
2.24%